Sophia Zoungas's Publications

Zoungas S, Villani M, de Courten B
Emergency treatment of hypoglycaemia: a guideline and evidence review.
Journal Article
2017
Diabet Med
Woodward Mark, Arima Hisatomi, Chalmers J., Zoungas Sophia, Gerstein Hertzel, Holman Rury, Reaven Peter, Coleman Ruth, Collaborators on Trials of Lowering Glucose (CONTROL) writing group
Microvascular outcomes in type 2 diabetes - Authors' reply.
Journal Article
2017
Lancet Diabetes Endocrinol
Woodward Mark, Arima Hisatomi, Chalmers J., Zoungas Sophia, Gerstein Hertzel, Holman Rury, Reaven Peter, Hayward Rodney, Craven Timothy, Coleman Ruth
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Journal Article
2017
Lancet Diabetes Endocrinol
Zoungas S., Navaneethan S., Kang A., Nigwekar S., Kulshrestha S., Strippoli G., Cass A., Gallagher M., Jardine M, Perkovic Vlado
Interventions for lowering plasma homocysteine levels in dialysis patients
Journal Article
2016
Cochrane Database of Systematic Reviews
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Mathew T., Polkinghorne K., Walker R., Cass A., Gallagher M.
The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study
Journal Article
2016
PLoS One
Zoungas S., Woodward Mark, Harrap S., Li Q., Marre M., Mohammedi K., Chalmers J., Patel Anushka
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes
Journal Article
2016
Diabetes Care
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Polkinghorne K., Walker R., Usherwood T., Gallagher M., Ilic D.
Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study
Journal Article
2016
BMC Nephrology
Zoungas S., Woodward Mark, Visseren F., Poulter N., Grobbee D., Mancia G., Harrap S., Heller S., Marre M., van der Leeuw J.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
Journal Article
2016
Diabetologia
Zoungas S., Hirakawa Y., Lisheng L., Woodward Mark, Arima H., Poulter N., Williams B., Hamet P., Mancia G., Harrap S.
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
Journal Article
2016
Journal of Hypertension
Zoungas S., Cooper M., Woodward Mark, Wong M., Matthews D., Poulter N., Williams B., Hamet P., Mancia G., Harrap S.
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Journal Article
2016
Diabetes Care
Zoungas S., Wong G., Poulter N., Kingwell B., Sullivan D., Woodward Mark, Nestel P., Williams B., Hillis G., Marre M.
Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes
Journal Article
2016
Circulation
Zoungas S., Smith K., Teede H., Ranasinha S., Villani M., Nanayakkara N., Tan C., Morgans A., Soldatos G.
Utilisation of emergency medical services for severe hypoglycaemia: An unrecognised health care burden
Journal Article
2016
Journal of Diabetes and Its Complications
Zoungas S., Kengne A., Hirakawa Y., Woodward Mark, Grobbee R., Poulter N., Cooper M., Jardine M, Matthews D., Chalmers J.
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score
Journal Article
2016
Diabetes, Obesity & Metabolism
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Walker R., Usherwood T., Gallagher M., Ranasinha S., Russell G.
Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease
Journal Article
2016
PLoS One
Zoungas S., Hirakawa Y., Lisheng L., Woodward Mark, Williams B., Mancia G., Harrap S., Marre M., Rodgers A, Mohammedi K.
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes
Journal Article
2016
Diabetes Care
Zoungas S., Teede H., Lo C., Usherwood T., Ranasinha S., Ilic D., Murphy K., Russell G.
Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods exploration
Journal Article
2016
Family Practice
Zoungas S., Huxley R., Woodward Mark, Blomster J., Poulter N., Mancia G., Harrap S., Hillis G., Chalmers J., Neal Bruce
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
Journal Article
2016
BMJ Open
Zoungas S., Kerr P., Lo C., Usherwood T., Cass A., Ranasinha S., Zimbudzi E., Fulcher G.
Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL
Journal Article
2016
Journal of Diabetes and Its Complications
Zoungas S., Hirakawa Y., Woodward Mark, Poulter N., Colagiuri S., Hamet P., Harrap S., Marre M., Matthews D., Mohammedi K.
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
Journal Article
2016
Cardiovascular Diabetology
Zoungas S., Glass Parisa, Kengne A., Woodward Mark, Visseren F., Poulter N., Grobbee D., Hamet P., van der Leeuw J., van der Graaf Y.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation
Journal Article
2015
Hypertension

Sophia Zoungas's Publications

Emergency treatment of hypoglycaemia: a guideline and evidence review.

Microvascular outcomes in type 2 diabetes - Authors' reply.

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.

Interventions for lowering plasma homocysteine levels in dialysis patients

The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study

Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes

Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes

Utilisation of emergency medical services for severe hypoglycaemia: An unrecognised health care burden

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score

Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease

Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes

Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods exploration

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial

Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study

Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country